Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Neonates

Sponsor
Ain Shams University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05493527
Collaborator
(none)
60
1
2
18.9
3.2

Study Details

Study Description

Brief Summary

A randomized controlled trial comparing Noninvasive high frequency oscillatory ventilation (NHFOV) and Noninvasive positive pressure ventilation (NIPPV) as post-extubation respiratory support in preterm neonates with respiratory distress syndrome(RDS)

Condition or Disease Intervention/Treatment Phase
  • Device: noninvasive high frequency oscillatory ventilation
  • Device: noninvasive positive pressure ventilation
N/A

Detailed Description

The use of noninvasive respiratory support (NRS) has increased in recent decades in Neonatal Intensive Care Unit (NICU) as a means to reduce ventilator-induced lung injury. Various modes of NRS are available and in common use. However despite extensive research, the optimal modality of noninvasive modes remain unknown.

Noninvasive high-frequency oscillatory ventilation (NHFOV) is a relatively new mode. It consists of the application of a continuous distending positive pressure with superimposed oscillations. It is a method of augmenting Continuous positive airway pressure (CPAP) support potentially combining the advantages of both high-frequency oscillatory ventilation and CPAP.

The new NHFOV technique offers improved carbon dioxide (CO2) removal and increased functional residual capacity. The superimposed oscillations of NHFOV are thought to help avoid gas trapping and upregulate mean airway pressure.

This technique is also characterized by lower tidal volume resulting in fewer barotraumas /volutraumas and not needing synchronization. NHFOV was considered a strengthened version of CPAP.

The hypothesis is that NHFOV might be superior to NIPPV as a post-extubation respiratory support strategy to avoid reintubation and subsequent complications and/or sequelae in preterm infants.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Preterm Neonates: A Randomized Controlled Trial
Actual Study Start Date :
Feb 1, 2021
Anticipated Primary Completion Date :
Aug 15, 2022
Anticipated Study Completion Date :
Aug 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: noninvasive high frequency oscillatory ventilation (NHFOV)

After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NHFOV as post extubation noninvasive respiratory support

Device: noninvasive high frequency oscillatory ventilation
A time-cycled, pressure-limited, and continuous-flow neonatal ventilator (SLE6000; SLE) was used for neonates assigned to the NHFOV group. The settings were as follows: a frequency of 10 Hertz ( range, 8-12 Hz); an inspiratory time of 50% (1:1) an oscillation amplitude of 35 centimeter of water column (cmH2O) (subsequent regulation range, 20-40 cmH2O) Oscillation amplitude would be regulated according to the level of carbon dioxide(CO2). Visible chest oscillation was not necessary because elimination of CO2 during NHFOV could also occur in the upper respiratory airway dead space Mean airway pressure (MAP) of 10 cm H2O ( range, 7-15) MAP was regulated according to an open lung recruitment strategy fraction of inspired oxygen (FIO2) regulated from 0.21 to 0.40 in order to maintain saturation from 90% to 95% as determined with a pulse oximeter.

Active Comparator: noninvasive positive pressure ventilation (NIPPV)

After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NIPPV as post extubation noninvasive respiratory support

Device: noninvasive positive pressure ventilation
NIPPV will be delivered by ventilator generating the targeted pressures. Infants will be on: Peep ranging from 5 to 10 cmH2O, Peak inspiratory pressure range 15-25 cmH2O Rate range 40-50 breath/minute FIO2 regulated from 0.21 to 0.40 in order to maintain saturation from 90% to 95% as determined with a pulse oximeter.

Outcome Measures

Primary Outcome Measures

  1. Re-intubation rate [72 hours]

    Percentage of Patients who failed weaning on the assigned noninvasive mode and needed reintubation to the total number of patients assigned to that mode.

Secondary Outcome Measures

  1. Days on the assigned non-invasive respiratory support [8 weeks or till patient discharge which comes first]

    To document number of days on the assigned non-invasive respiratory support

  2. Days on supplemental oxygen [8 weeks or till patient discharge which comes first]

    To document number of days on supplemental oxygen

  3. Duration of admission [8 weeks or till patient discharge which comes first]

    To document total number of days of admission

  4. Mortality rate [8 weeks or till patient death which comes first]

    To document incidence of mortality during hospitalization

  5. Lung ultrasound score [Before extubation and after 2 hours on assigned mode]

    lung ultrasound was performed to all patients before extubation and 2 hours after extubation to assess lung aeration. Score ranges from 0 to 18 .Higher score indicates worse lung aeration.

  6. Co2 change [Before extubation and after 2 hours on assigned mode]

    Co2 change in patients on assigned mode using venous blood gases performed before extubation and 2 hours after.

  7. Oxygen requirement [Before extubation and after 2 hours on assigned mode]

    Fraction of inspired oxygen required to patients on assigned mode

  8. Incidence of feeding intolerance [8 weeks or till patient weaning from assigned mode which comes first]

    Percentage of Patients who developed feeding intolerance on the assigned noninvasive mode to the total number of patients assigned to that mode.

  9. Days to reach full intake [8 weeks or till patient discharge which comes first]

    Number of days needed by each patient to reach full intake

  10. Intracranial hemorrhage [8 weeks or till patient weaning from assigned mode which comes first]

    Percentage of patients developing intracranial hemorrhage on the assigned noninvasive mode to the total number of patients assigned to that mode.

  11. Pneumothorax [8 weeks or till patient weaning from assigned mode which comes first]

    Percentage of patients developing pneumothorax on the assigned noninvasive mode to the total number of patients assigned to that mode.

  12. Incidence of occurrence of Nasal trauma [8 weeks or till patient weaning from assigned mode which comes first]

    Percentage of patients developing nasal trauma on the assigned noninvasive mode to the total number of patients assigned to that mode.

  13. incidence of bronchopulmonary dysplasia [8 weeks or till patient discharge which comes first]

    Need for supplemental oxygen for at least 28 days, percentage of these patients on the assigned noninvasive mode to the total number of patients assigned to that mode.

  14. Severity of respiratory distress [Before extubation and and after 2 hours on assigned mode]

    Assessment of work of breathing on assigned mode by Downe 's score. Score ranges from 0 till 10 . Higher score indicates worse work of breathing.

  15. Need for Postnatal Steroids [8 weeks or till patient discharge which comes first]

    Percentage of patients who needed postnatal steroids administration

  16. Chest x ray change [Before extubation and and after 2 hours on assigned mode]

    Chest x ray grading of RDS performed to patient before and after the assigned mode to compare lung aeration degree.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Minute to 1 Month
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Preterm neonates with gestational age ≤ 35 weeks.

  2. Neonates that were on invasive mechanical ventilation for at least 48 hours eligible for extubation

Exclusion Criteria:
  1. Patients with major upper or lower airway anomalies.

  2. Patients with significant congenital anomalies including cardiac, abdominal or respiratory.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neonatal Intensive Care Units (NICUs), Ain Shams University Cairo Abbasia Egypt 11517

Sponsors and Collaborators

  • Ain Shams University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sondos Ahmed Salaheldin Ahmed, Assistant lecturer, Ain Shams University
ClinicalTrials.gov Identifier:
NCT05493527
Other Study ID Numbers:
  • MD 90/2020
First Posted:
Aug 9, 2022
Last Update Posted:
Aug 9, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sondos Ahmed Salaheldin Ahmed, Assistant lecturer, Ain Shams University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2022